Perigon Wealth Management, LLC reports 0.92% decrease in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Perigon Wealth Management, LLC
Latest Disclosed Ownership	72,004 shares
Latest Disclosed Value	$ 4,367,023

On April 10, 2026 - Perigon Wealth Management, LLC filed a 13F-HR form disclosing ownership of 72,004 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $3,774,450 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 72,670 shares of Bristol-Myers Squibb Company. This represents a change in shares of -0.92% during the quarter. The current value of the position is $3,415,150 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-10	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	72,004	-666	-0.92	4,367	11.43	0.0792
2026-01-16	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	72,670	13,485	22.78	3,920	46.83	0.0701
2025-10-17	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	59,185	5,655	10.56	2,669	7.75	0.0544
2025-07-16	2025-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	53,530	-8,768	-14.07	2,478	-34.80	0.0579
2025-04-23	2025-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	62,298	2,205	3.67	3,800	12.13	0.0975
2025-01-22	2024-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	60,093	11,536	23.76	3,388	34.87	0.0832
2024-10-16	2024-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	48,557	8,169	20.23	2,512	49.79	0.0663
2024-08-02	2024-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	40,388	-1,751	-4.16	1,677	-26.61	0.0486
2024-04-29	2024-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	42,139	-5,720	-11.95	2,285	-6.92	0.0693
2024-01-29	2023-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	47,859	2,321	5.10	2,456	-7.08	0.0803
2023-10-30	2023-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	45,538	-10,299	-18.44	2,643	-25.99	0.1071
2023-08-02	2023-06-30	13F/A-1	BRISTOL-MYERS SQUIBB	COM	110122108	55,837	29,337	110.71	3,571	94.44	0.1403
2023-08-02	2023-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	55,837	29,337		3,571		0.1403
2023-05-03	2023-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	26,500	-530	-1.96	1,837	-5.56	0.1044
2023-05-01	2022-12-31	13F/A-1	BRISTOL-MYERS SQUIBB	COM	110122108	27,030	9,343	52.82	1,945	54.65	0.1205
2023-02-14	2022-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	27,030			1,945
2022-12-13	2022-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	17,687	-141	-0.79	1,257	-8.45	0.1086
2022-08-11	2022-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	17,828	941	5.57	1,373	11.35	0.1147
2022-05-16	2022-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	16,887	5,956	54.49	1,233	80.79	0.0871
2022-02-11	2021-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	10,931	-14,891	-57.67	682	-55.37	0.0488
2021-11-01	2021-09-30	13F/A-1	BRISTOL-MYERS SQUIBB	COM	110122108	25,822	-4,922	-16.01	1,528	-25.61	0.1326
2021-07-19	2021-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	30,744	-2,255	-6.83	2,054	-1.39	0.1827
2021-05-17	2021-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	32,999	1,670	5.33	2,083	7.21	0.2124
2021-01-28	2020-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	31,329	3,990	14.59	1,943	17.90	0.2257
2020-11-03	2020-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	27,339	-3,274	-10.69	1,648	-8.44	0.2303
2020-07-29	2020-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	30,613	3,048	11.06	1,800	10.84	0.2854
2020-04-17	2020-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	27,565	-1,328	-4.60	1,624	-10.77	0.3023
2020-01-13	2019-12-31	13F	BRISTOL MYERS SQUIBB	COM	110122108	28,893	21,690	301.12	1,820	387.94	0.3715
2019-10-25	2019-09-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	7,203	-2,055	-22.20	373	-11.19	0.0876
2019-08-05	2019-06-30	13F	BRISTOL MYERS SQUIBB	COM	110122108	9,258	-35	-0.38	420	-1.87	0.0983
2019-05-15	2019-03-31	13F	Bristol Myers Squibb	COM	110122108	9,293	-400	-4.13	428	-10.46	0.0995
2019-02-11	2018-12-31	13F	Bristol Myers Squibb	COM	110122108	9,693	1,700	21.27	478	-3.63	0.1220
2018-11-13	2018-09-30	13F	Bristol Myers Squibb	COM	110122108	7,993	-475	-5.61	496	5.76	0.1222
2018-08-09	2018-06-30	13F/A-2	Bristol Myers Squibb	COM	110122108	8,468	75	0.89	469	-11.68	0.1410
2018-08-08	2018-06-30	13F/A-1	Bristol Myers Squibb	COM	110122108	8,393	0		531		0.2140
2018-08-07	2018-06-30	13F	Bristol Myers Squibb	COM	110122108	8,393	0		531		0.2140
2018-05-14	2018-03-31	13F	Bristol Myers Squibb	COM	110122108	8,393	1,520	22.12	531	26.13	0.1956
2018-02-14	2017-12-31	13F	Bristol Myers Squibb	COM	110122108	6,873	200	3.00	421	-0.94	0.1571
2017-12-05	2017-09-30	13F	Bristol Myers Squibb	COM	110122108	6,673	-5,780	-46.41	425	-38.76	0.1379
2017-09-12	2017-06-30	13F	Bristol Myers Squibb	COM	110122108	12,453	-1,125	-8.29	694	-5.96	0.1510
2017-06-05	2017-03-31	13F	Bristol Myers Squibb	COM	110122108	13,578	185	1.38	738	-3.78	0.1566
2017-03-07	2016-12-31	13F	Bristol Myers Squibb	COM	110122108	13,393	683	5.37	767	11.97	0.1675
2016-11-16	2016-09-30	13F	Bristol Myers Squibb	COM	110122108	12,710	-487	-3.69	685	-29.45	0.1759
2016-08-19	2016-06-30	13F	Bristol Myers Squibb	COM	110122108	13,197	-20	-0.15	971	14.50	0.2581
2016-06-03	2016-03-31	13F	Bristol Myers Squibb	COM	110122108	13,217	0	0.00	848	-6.81	0.2648
2016-03-04	2015-12-31	13F	Bristol Myers Squibb	COM	110122108	13,217	-730	-5.23	910	10.04	0.2512
2015-12-02	2015-09-30	13F	Bristol Myers Squibb	COM	110122108	13,947	0	0.00	827	-10.88	0.2454
2015-08-31	2015-06-30	13F	Bristol Myers Squibb	COM	110122108	13,947	167	1.21	928	4.39	0.2443
2015-05-11	2015-03-31	13F	Bristol Myers Squibb	COM	110122108	13,780	-250	-1.78	889	7.37	0.2438
2015-02-18	2014-12-31	13F	Bristol Myers Squibb	COM	110122108	14,030	-375	-2.60	828	12.35	0.2488
2014-11-17	2014-09-30	13F	Bristol Myers Squibb	COM	110122108	14,405	-935	-6.10	737	-0.94	0.2194
2014-08-12	2014-06-30	13F	Bristol Myers Squibb	COM	110122108	15,340	490	3.30	744	-3.50	0.2121
2014-05-12	2014-03-31	13F	Bristol Myers Squibb	COM	110122108	14,850	1,050	7.61	771	5.18	0.4245
2014-02-18	2013-12-31	13F	Bristol Myers Squibb	COM	110122108	13,800	-3,887	-21.98	733	-41.69	0.4065
2022-11-14	2011-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	17,687	17,687		1,257		0.1086

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.